Anti-nerve growth factor monoclonal antibodies – Solensia
Solensia
Published 10 September 2025
- Veterinary Medicines Directorate (2024) Summary of Product Characteristics: Solensia 7 mg/ml solution for injection for cats [DEFRA] [online]. Available from: https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_2034950.PDF [Accessed 8 September 2025]
- Veterinary Medicines Directorate (2025) Post Authorisation Assessments: Solensia 7 mg/ml solution for injection for cats [DEFRA] [online]. Available from: https://www.vmd.defra.gov.uk/productinformationdatabase/files/PAA_Documents/PAA_2239476.PDF [Accessed 8 September 2025]
- Veterinary Medicines Directorate (2025) VMD response to concerns raised following media reports of serious adverse events in cats administered Solensia [DEFRA] [online]. https://www.gov.uk/government/news/solensia-7-mgml-solution-for-injection-for-cats [Accessed 8 September 2025]
- Veterinary Medicines. Solensia 7 mg/ml solution for injection [European Medicines Agency] [online]. Available from: https://medicines.health.europa.eu/veterinary/en/600000001761 [Accessed 8 September 2025]
Claiming CPD for reading inFOCUS articles
Reading and reflecting on articles can count towards your CPD, and we have a template to help you with the process.
Online full-text available to Library members
A range of library membership packages is available and MRCVS vets and RVNs can join the library for a heavily subsidised, annual fee.
Leave a Reply
Want to join the discussion?Feel free to contribute!